FDA Considers Guidance For Nano-Engineered Supplements
This article was originally published in The Tan Sheet
Executive Summary
The Center for Food Safety and Applied Nutrition is considering guidance on the regulatory implications of reformulating dietary supplements with nanomaterials, according to senior FDA staff
You may also be interested in...
FDA Regulatory Science Infrastructure Gets $25 Million Push In Budget
A $25 million, cross-center scientific modernization effort proposed in FDA's fiscal 2011 budget targets gaining the expertise and infrastructure needed to assess products of the future - such as biosimilars and those based on stem cells and nanotechnology
FDA Regulatory Science Infrastructure Gets $25 Million Push In Budget
A $25 million, cross-center scientific modernization effort proposed in FDA's fiscal 2011 budget targets gaining the expertise and infrastructure needed to assess products of the future - such as biosimilars and those based on stem cells and nanotechnology
FDA Regulatory Science Infrastructure Gets $25 Million Push In Budget
A $25 million, cross-center scientific modernization effort proposed in FDA's fiscal 2011 budget targets gaining the expertise and infrastructure needed to assess products of the future - such as biosimilars and those based on stem cells and nanotechnology